PDF(2092 KB)
Cost-effectiveness of camrelizumab combined with chemotherapy vs.chemotherapy alone as first-line treatment for advanced squamous non-small cell lung cancer
SUN Zheng, LI Yong
Chinese Journal of Hospital Pharmacy ›› 2022, Vol. 42 ›› Issue (20) : 2148-2152.
PDF(2092 KB)
PDF(2092 KB)
Cost-effectiveness of camrelizumab combined with chemotherapy vs.chemotherapy alone as first-line treatment for advanced squamous non-small cell lung cancer
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
